Federal contractor profile
THE GLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT INC
UEI CA1RNRESAZU6CAGE 52VM4Company website ↗
Active
Overview
- Legal name
- THE GLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT INC
- Registered location
- NEW YORK, NY, USA
- Website
- Company website ↗
- Primary NAICS
- 541714 — Research and Development in Biotechnology (except Nanobiotechnology)
- Latest award activity
- Aug 26, 2026
Read company summary
THE GLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT INC is associated with UEI CA1RNRESAZU6 and CAGE 52VM4 in public federal records. AcornBids currently links 1 prime award totaling $2.5M in obligations to this entity. Its largest recorded federal customer by obligations is Department of Health and Human Services. Its recorded federal awards include work classified as Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology). These categories describe the loaded award records, not a complete list of company capabilities. Its primary SAM.gov NAICS is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)). Its public SAM.gov registration lists NEW YORK, NY, USA.
At a glance
Lifetime prime obligations$2.5M
Prime awards1
Awards with future end dates1
Top-agency concentration
Not available
Why this customer concentration
Detailed agency totals are not available in this stored profile.
Largest positive coded-agency total ÷ all positive coded-agency totals × 100
Missing data is shown as unavailable.
Prime contract obligations across loaded award records. Obligations are not revenue or contract ceilings. Summary updated Oct 7, 2026. Refresh pending; these totals may be out of date.
Business information
Public SAM.gov registration details.
- Legal name
- THE GLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT INC
- UEI
- CA1RNRESAZU6
- CAGE
- 52VM4
- Registered address
- 80 PINE ST FL 20, NEW YORK, NY, 10005, USA
- Registration status
- Active
- Primary NAICS
- 541714 — Research and Development in Biotechnology (except Nanobiotechnology)
- SAM activation
- Jun 11, 2026
- Initial registration
- May 12, 2008
- Entity start
- Jul 24, 2000
- SAM updated
- Jun 11, 2026
- Registration expires
- Jun 10, 2027
- Fiscal year end
- Dec 31
- Place of incorporation
- DE, USA
Research brief
Source facts
- Loaded prime-award records link 1 awards and $2,475,623 in reported obligations to this legal entity. Source
- Recorded awards include Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) (NAICS 541715); this classification is not proof of every company capability. Source
- An example award describes: TO DEVELOP A NOVEL MODULATOR TARGETING PROTEOSTASIS FOR THE TREATMENT OF M. TUBERCULOSIS. Source
Federal award analysis
Net transaction obligations by federal fiscal period.
Selected transaction obligations$2.5M
Prime contracts
Reported transaction obligations by federal fiscal period; includes deobligations. Missing transactions are not estimated. Coverage: 1 of 1 selected awards. Select a period to explore its awards.
Recent federal awards
Prime contract awards. Select an award to review its history and source evidence.
| Award / description | Awarding agency | Obligations | Start date | End date |
|---|---|---|---|---|
| 75N93024C00008TO DEVELOP A NOVEL MODULATOR TARGETING PROTEOSTASIS FOR THE TREATMENT OF M. TUBERCULOSIS. | Department of Health and Human Services | $2.5M | May 10, 2024 | Feb 28, 2027 |
Upcoming positioning windows
Modeled recompete windows are estimates, not announced solicitations or guarantees.
Registration, certifications & contacts
| Registration evidence | Date |
|---|---|
| SAM updated | Jun 11, 2026 |
| Source loaded | Sep 26, 2026 |
| Initial registration | May 12, 2008 |
| Entity start | Jul 24, 2000 |
| Industry | Reported size status |
|---|---|
| 541714 — Research and Development in Biotechnology (except Nanobiotechnology) | Not reported |
| 541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | Not reported |
| Contact | Role | Published contact methods | Evidence | Source date |
|---|---|---|---|---|
| ANN NGUYEN | Government business | Contact method not published | SAM registration | Not available |
| ANGELA VANDERPLOEG | Alternate government business | Contact method not published | SAM registration | Not available |
| ANN NGUYEN | Electronic business | Contact method not published | SAM registration | Not available |
| ANGELA VANDERPLOEG | Alternate electronic business | Contact method not published | SAM registration | Not available |
Registered industries
- 541714 — Research and Development in Biotechnology (except Nanobiotechnology)
- 541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Registration classifications and published certificates do not by themselves establish eligibility for a particular solicitation. View SAM source
Related companies worth researching
Explore the customer, work and award-size evidence behind each match.
1 awards
1 awards
1 awards
About THE GLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT INC
What products and services appear in its federal awards?
Recorded award industries: 541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology).
Recorded products and services: AN12 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH.
Examples from recent award records:
These records describe federal award work, not every company capability. Review the award evidence.
Where is the company registered?
80 PINE ST FL 20, NEW YORK, New York 10005, United States
Registered location from SAM.gov; award performance locations may differ.
What is its primary registered industry?
541714 — Research and Development in Biotechnology (except Nanobiotechnology).
Primary SAM.gov NAICS classification.
Which federal agencies are represented in its awards?
Department of Health and Human Services.
Data coverage and methodology
Sources: SAM.gov registration, USAspending awards and transactions, and linked supporting records. Prime contract obligations, IDV ceilings and assistance amounts are kept separate. Missing records are not zero activity. Company claims are labeled separately. Recompete signals are rule-based scores out of 100. Positioning windows are AcornBids estimates.
Disclosed relationships only. Missing records do not establish that a contractor has no partners. Ambiguous parent award identifiers are excluded.
Recently viewed companies
Keep your research moving
Save this company, track changes, and evaluate upcoming work against your targets.
Save to my research Find my fit